SABCS 2022 Conference Coverage


 

SABCS 2022 Phase 2 Expansion (VERITAC) of a Phase 1/2 Study: ARV-471, a PROTAC® ER Degrader in Advanced ER+/HER2- BC

146 views
December 22, 2022
Comments 0
Login to view comments. Click here to Login